Co., Inc. (NYSE: MRK) has initiated a pivotal Phase 3 clinical trial, waveLINE-010, to evaluate the efficacy of its investigational drug zilovertamab vedotin in treating patients with previously ...

The company's blockbuster drug Keytruda contributed $29.48 billion in sales in 2024, but the first of its patent expirations begins in 2028.

Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the ...

The healthcare pioneer shares insights on transformative diagnostics where precision medicine meets women’s health innovation ...

The markets are likely to show some reactions to Donald Trump’s trade war, sparked by the US imposing sweeping tariffs on ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for belzutifan for the treatment of adult and pediatric patients aged 12 years and ...

In the first randomized trial of its kind, researchers found that adding chemoradiation to adjuvant chemotherapy did not ...

Get Wall Street's Hottest Chart Every Morning On Thursday, Dr. Reddy's Laboratories Ltd RDY stock is trading lower after the company released third-quarter 2025 earnings. The pharma company ...

BURLINGTON, Mass.--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, and Opentrons Labworks, Inc., a leader in lab automation and ...

The increasing demand for biopharmaceuticals is a significant driver of the Global Bioanalytical Services market Industry US, NY, UNITED STATES, January 22, 2025 /EINPresswire / -- Global ...